J. Febbo William's Insider Trades & SAST Disclosures
J. Febbo William's most recent trade in OptimizeRx Corp was a trade of 401 Common Stock done at an average price of $6.6 . Disclosure was reported to the exchange on Feb. 14, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern J. Febbo William.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| OptimizeRx Corp | William J. Febbo | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.64 per share. | 14 Feb 2025 | 401 | 600,852 (4%) | 0% | 6.6 | 2,663 | Common Stock |
| OptimizeRx Corp | William J. Febbo | Director, CEO | Purchase of securities on an exchange or from another person at price $ 5.01 per share. | 12 Dec 2024 | 20,000 | 601,253 (4%) | 0% | 5.0 | 100,220 | Common Stock |
| Augmedix Inc | William J. Febbo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jul 2024 | 21,598 | 162,583 | - | - | Common Stock | |
| Augmedix Inc | William J. Febbo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jul 2024 | 21,598 | 0 | - | - | Restricted Stock Units | |
| OptimizeRx Corp | William J. Febbo | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Apr 2024 | 28,895 | 57,790 | - | - | Restricted Stock Units | |
| OptimizeRx Corp | William J. Febbo | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Apr 2024 | 28,895 | 582,035 (3%) | 0% | 0 | Common Stock | |
| OptimizeRx Corp | William J. Febbo | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.35 per share. | 18 Apr 2024 | 782 | 581,253 (3%) | 0% | 9.4 | 7,312 | Common Stock |
| OptimizeRx Corp | William J. Febbo | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2024 | 60,000 | 538,144 (3%) | 0% | 0 | Common Stock | |
| OptimizeRx Corp | William J. Febbo | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 15,000 | 553,144 (3%) | 0% | 0 | Common Stock | |
| OptimizeRx Corp | J. William Febbo | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2024 | 9,628 | 481,028 (3%) | 0% | 0 | Common Stock | |
| OptimizeRx Corp | Febbo William J. | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2024 | 9,628 | 0 | - | - | Restricted Stock Units | |
| OptimizeRx Corp | J. Febbo William | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.25 per share. | 09 Jan 2024 | 2,884 | 478,144 (3%) | 0% | 13.3 | 38,213 | Common Stock |
| Augmedix Inc | William J. Febbo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jul 2023 | 21,598 | 21,598 | - | - | Restricted Stock Units | |
| Modular Medical Inc | William J. Febbo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 2,500 | 91,605 (0%) | 0% | - | Common Stock | |
| LifeMD Inc | William J. Febbo | Director, Consultant | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 75,000 | 450,000 | - | 0 | Common Stock | |
| LifeMD Inc | William J. Febbo | Director, Consultant | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 37,500 | 37,500 | - | - | Employee Stock Option (Right to Buy) | |
| Augmedix Inc | William J. Febbo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2023 | 52,632 | 140,985 | - | - | Common Stock | |
| Augmedix Inc | William J. Febbo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2023 | 52,632 | 0 | - | - | Restricted Stock Units | |
| OptimizeRx Corp | William J. Febbo | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2023 | 161,698 | 161,698 | - | - | Stock Option | |
| OptimizeRx Corp | William J. Febbo | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2023 | 86,685 | 86,685 | - | - | Restricted Stock Units | |
| Modular Medical Inc | William J. Febbo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 2,500 | 89,105 (0%) | 0% | - | Common Stock | |
| OptimizeRx Corp | William J. Febbo | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2023 | 9,628 | 471,400 (3%) | 0% | - | Common Stock | |
| OptimizeRx Corp | William J. Febbo | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2023 | 9,628 | 9,628 | - | - | Restricted Stock Units | |
| Modular Medical Inc | William J. Febbo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2022 | 2,500 | 86,605 (0%) | 0% | - | Common Stock | |
| Modular Medical Inc | William J. Febbo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 2,500 | 84,105 (0%) | 0% | - | Common Stock | |
| OptimizeRx Corp | William J. Febbo | Director, CEO | Purchase of securities on an exchange or from another person at price $ 15.29 per share. | 19 Aug 2022 | 10,700 | 461,772 (3%) | 0% | 15.3 | 163,642 | Common Stock |
| OptimizeRx Corp | William J. Febbo | Director, CEO | Purchase of securities on an exchange or from another person at price $ 16.18 per share. | 19 Aug 2022 | 5,400 | 451,072 (3%) | 0% | 16.2 | 87,364 | Common Stock |
| Modular Medical Inc | William J. Febbo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2022 | 2,500 | 81,605 (0%) | 0% | - | Common Stock | |
| Augmedix Inc | William J. Febbo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 52,632 | 52,632 | - | - | Restricted Stock Units | |
| Modular Medical Inc | William J. Febbo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 5,981 | 79,105 (0%) | 0% | - | Common Stock | |
| Augmedix Inc | William J. Febbo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2022 | 50,000 | 50,000 | - | - | Employee Stock Option (right to buy) | |
| Modular Medical Inc | William J. Febbo | Director | Grant, award, or other acquisition of securities at price $ 4.02 per share. | 03 Mar 2022 | 20,000 | 73,124 (0%) | 0% | 4.0 | 80,400 | Common Stock |
| OptimizeRx Corp | William J. Febbo | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 43.38 per share. | 18 Feb 2022 | 9,200 | 453,138 (3%) | 0% | 43.4 | 399,087 | Common Stock |
| OptimizeRx Corp | William J. Febbo | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 44.12 per share. | 18 Feb 2022 | 7,066 | 446,072 (3%) | 0% | 44.1 | 311,766 | Common Stock |
| OptimizeRx Corp | William J. Febbo | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 44.96 per share. | 18 Feb 2022 | 400 | 445,672 (3%) | 0% | 45.0 | 17,984 | Common Stock |
| Modular Medical Inc | William J. Febbo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2022 | 45,586 | 53,124 (0%) | 0% | - | Common Stock | |
| Modular Medical Inc | William J. Febbo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2022 | 45,586 | 45,586 | - | - | Common stock purchase warrant | |
| Modular Medical Inc | William J. Febbo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2022 | 45,586 | 0 | - | - | Convertible Promissory Note | |
| Modular Medical Inc | William J. Febbo | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 06 Feb 2022 | 23,229 | 23,229 | - | - | Common stock purchase warrant | |
| OptimizeRx Corp | William J. Febbo | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 47.57 per share. | 18 Jan 2022 | 8,226 | 462,638 (3%) | 0% | 47.6 | 391,327 | Common Stock |
| OptimizeRx Corp | William J. Febbo | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 46.91 per share. | 18 Jan 2022 | 8,140 | 470,864 (3%) | 0% | 46.9 | 381,888 | Common Stock |
| OptimizeRx Corp | William J. Febbo | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 48.52 per share. | 18 Jan 2022 | 300 | 462,338 (3%) | 0% | 48.5 | 14,557 | Common Stock |
| OptimizeRx Corp | William J. Febbo | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 07 Jan 2022 | 9,627 | 19,256 | - | - | Unvested Restricted Stock Award | |
| OptimizeRx Corp | William J. Febbo | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 07 Jan 2022 | 9,627 | 479,004 (3%) | 0% | - | Common Stock | |
| Modular Medical Inc | William J. Febbo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2021 | 3,329 | 7,538 (0%) | 0% | - | Common Stock | |
| OptimizeRx Corp | William J. Febbo | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 82.18 per share. | 15 Nov 2021 | 16,666 | 486,043 (3%) | 0% | 82.2 | 1,369,612 | Common Stock (pursuant to 10B5-1 plan) |
| OptimizeRx Corp | William J. Febbo | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 182,398 | 182,398 | - | - | Performance Stock Units | |
| OptimizeRx Corp | William J. Febbo | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 84.20 per share. | 15 Oct 2021 | 16,666 | 502,709 (3%) | 0% | 84.2 | 1,403,277 | Common Stock (pursuant to 10B5-1 plan) |
| OptimizeRx Corp | William J. Febbo | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 65.74 per share. | 15 Sep 2021 | 16,666 | 519,375 (3%) | 0% | 65.7 | 1,095,623 | Common Stock (pursuant to 10B5-1 plan) |
| OptimizeRx Corp | William J. Febbo | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Sep 2021 | 8,600 | 536,041 (3%) | 0% | - | Common Stock | |
| OptimizeRx Corp | William J. Febbo | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 60.46 per share. | 16 Aug 2021 | 16,666 | 544,641 (3%) | 0% | 60.5 | 1,007,626 | Common Stock (pursuant to 10B5-1 plan) |
| OptimizeRx Corp | William J. Febbo | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Mar 2021 | 394,739 | 0 | - | - | Stock Option | |
| OptimizeRx Corp | William J. Febbo | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.21 per share. | 24 Mar 2021 | 394,739 | 588,017 (4%) | 2% | 3.2 | 1,267,112 | Common Stock |
| OptimizeRx Corp | William J. Febbo | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 46.10 per share. | 24 Mar 2021 | 80,000 | 193,278 (1%) | 0% | 46.1 | 3,688,000 | Common Stock |
| OptimizeRx Corp | William J. Febbo | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.44 per share. | 24 Mar 2021 | 26,710 | 561,307 (3%) | 0% | 47.4 | 1,267,122 | Common Stock |
| OptimizeRx Corp | William J. Febbo | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 50.50 per share. | 24 Mar 2021 | 20,000 | 273,278 (1%) | 0% | 50.5 | 1,010,000 | Common Stock |
| OptimizeRx Corp | William J. Febbo | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 28,883 | 28,883 | - | - | Unvested Restricted Stock Award | |
| OptimizeRx Corp | William J. Febbo | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2020 | 21,187 | 229,719 (1%) | 0% | - | Common Stock | |
| OptimizeRx Corp | William J. Febbo | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2020 | 21,187 | 42,372 | - | - | Unvested Restricted Stock Award | |
| OptimizeRx Corp | William J. Febbo | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.21 per share. | 24 Jun 2020 | 45,261 | 208,528 (1%) | 0% | 3.2 | 145,288 | Common Stock |
| OptimizeRx Corp | William J. Febbo | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2020 | 45,261 | 394,739 | - | - | Stock Option |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges